4/20/2011

Two case studies in the Journal of the American Medical Association suggest that whole genome sequencing could better identify gene mutations that play a role in certain diseases and tailor treatments for cancer patients. In one case study, researchers were able to spare a 39-year-old patient with a type of leukemia from having to undergo stem cell transplantation after finding a genetic defect that would make the drug ATRA particularly effective. Researchers note that cost and the time it takes to perform the analysis are drawbacks to such sequencing.

Full Story:
HealthDay News

Related Summaries